Artisan Partners Limited Partnership Ascendis Pharma A/S Transaction History
Artisan Partners Limited Partnership
- $58.2 Billion
- Q1 2025
A detailed history of Artisan Partners Limited Partnership transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 4,256,627 shares of ASND stock, worth $673 Million. This represents 1.14% of its overall portfolio holdings.
Number of Shares
4,256,627
Previous 4,450,420
4.35%
Holding current value
$673 Million
Previous $613 Million
8.28%
% of portfolio
1.14%
Previous 0.98%
Shares
28 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.63 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$866 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$825 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$709 Million0.4% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.05MShares$483 Million0.31% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.82B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...